# 24 Vs 48 Hours of Cefazolin or Cefuroxime as Prophylaxis

> **NCT04303390** · PHASE4 · COMPLETED · sponsor: **Saud Al Babtain Cardiac Center** · enrollment: 568 (actual)

## Conditions studied

- Surgical Site Infection

## Interventions

- **DRUG:** Cefuroxime
- **DRUG:** Cefazolin
- **OTHER:** 24 hours
- **OTHER:** 48 hours

## Key facts

- **NCT ID:** NCT04303390
- **Lead sponsor:** Saud Al Babtain Cardiac Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-06
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 568 (ACTUAL)
- **Last updated:** 2023-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04303390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04303390, "24 Vs 48 Hours of Cefazolin or Cefuroxime as Prophylaxis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04303390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*